Elusys Therapeutics' Series C Round

Elusys Therapeutics raised a round of funding on July 19, 2001.

Elusys Therapeutics, Inc. is a privately-held biopharmaceutical company focused on the development of targeted anti-infective therapeutics using Heteropolymer (HP) Antibodies for the treatment of infe…

Articles about Elusys Therapeutics' Series C Round: